Comparing a single-day swabbing regimen with an established 3-day protocol for MRSA decolonization control H. Frickmann, N.G. Schwarz, A. Hahn, A. Ludyga,

Slides:

Advertisements

Similar presentations

ST2249-MRSA-III: a second major recombinant methicillin-resistant Staphylococcus aureus clone causing healthcare infection in the 1970s G.R. Nimmo, J.A.

Advertisements

Gram-positive infections: lessons learnt and novel solutions

T. Khawaja, J. Kirveskari, S. Johansson, J. Väisänen, A

Cryptococcosis—the impact of delay to diagnosis

Weight-based antibiotic dosing in a real-world European study of complicated skin and soft-tissue infections due to methicillin-resistant Staphylococcus.

New epidemiology of Staphylococcus aureus infection in Asia

Bloodstream infections among carriers of carbapenem-resistant Klebsiella pneumoniae: etiology, incidence and predictors S. Amit, H. Mishali, T. Kotlovsky,

Pathophysiology and burden of infection in patients with diabetes mellitus and peripheral vascular disease: focus on skin and soft-tissue infections

G. Cornaglia, A. Lönnroth, M. Struelens

I. López-Hernández, M. Delgado Valverde, N. Batista Díaz, A. Pascual

Incidence and outcome of Staphylococcus aureus endocarditis—a 10-year single-centre northern European experience H. Asgeirsson, A. Thalme, M. Kristjansson,

Molecular characterization of methicillin-resistant Staphylococcus aureus isolated over a 2-year period in a Qatari hospital from multinational patients

Effectiveness of a hospital-wide selective screening programme for methicillin-resistant Staphylococcus aureus (MRSA) carriers at hospital admission to.

European perspective and update on the management of nosocomial pneumonia due to methicillin-resistant Staphylococcus aureus after more than 10 years.

The efficacy and safety of daptomycin: first in a new class of antibiotics for Gram- positive bacteria M.J. Rybak Clinical Microbiology and Infection

Migrant health—a cause for concern?

European perspective and update on the management of complicated skin and soft tissue infections due to methicillin-resistant Staphylococcus aureus after.

Maternal colonization with Staphylococcus aureus and Group B streptococcus is associated with colonization in newborns A. Roca, A. Bojang, B. Camara,

Screening of migrants for tuberculosis identifies patients with multidrug-resistant tuberculosis but is not sufficient P. Helbling Clinical Microbiology.

Clinical impact of antibiotic-resistant Gram-positive pathogens

Cost-effectiveness of universal MRSA screening on admission to surgery

Clonal complex 398 methicillin-susceptible Staphylococcus aureus bloodstream infections are associated with high mortality K. Bouiller, H. Gbaguidi-Haore,

European perspective and update on the management of complicated skin and soft tissue infections due to methicillin-resistant Staphylococcus aureus after.

Antimicrobial drug use and infection control practices associated with the prevalence of methicillin-resistant Staphylococcus aureus in European hospitals

Clinical impact and prevalence of MRSA CC398 and differences between MRSA-TetR and MRSA-TetS in an area of Spain with a high density of pig farming: a.

Longitudinal investigation of nasopharyngeal methicillin-resistant Staphylococcus aureus colonization in early infancy: The PATCH birth cohort study

Evidence of transmission of a Panton-Valentine leukocidin-positive community-acquired methicillin-resistant Staphylococcus aureus clone: a family affair

Is the prevalence of antibiotic-resistant organisms changing in Canadian hospitals? Comparison of point-prevalence survey results in 2010 and 2012 V.

Use of surveillance cultures and enteral vancomycin to control methicillin-resistant Staphylococcus aureus in a paediatric intensive care unit K. Thorburn,

W. Witte, B. Pasemann, C. Cuny Clinical Microbiology and Infection

Rapid genotyping of methicillin-resistant Staphylococcus aureus (MRSA) isolates using miniaturised oligonucleotide arrays S. Monecke, R. Ehricht Clinical.

Do we need new antibiotics?

Maternal colonization with Staphylococcus aureus and Group B streptococcus is associated with colonization in newborns A. Roca, A. Bojang, B. Camara,

A longitudinal analysis of chronic MRSA and Pseudomonas aeruginosa co-infection in cystic fibrosis: A single-center study Maret L. Maliniak, Arlene A.

A new multiplex PCR for easy screening of methicillin-resistant Staphylococcus aureus SCCmec types I–V K. Boye, M.D. Bartels, I.S. Andersen, J.A. Møller,

Low prevalence of methicillin-resistant Staphylococcus aureus with reduced susceptibility to glycopeptides in Belgian hospitals C. Nonhoff, O. Denis,

Epidemiology of opportunistic infections in AIDS patients

A variant of the Southern German clone of methicillin-resistant Staphylococcus aureus is predominant in Croatia A. Budimir, R.H. Deurenberg, Z. Bošnjak,

Bacterial resistance—the clinical challenge

Evaluation of vancomycin MIC creep in methicillin-resistant Staphylococcus aureus infections—a systematic review and meta-analysis R. Diaz, V. Afreixo,

Body site colonization in patients with community-associated methicillin-resistant Staphylococcus aureus and other types of S. aureus skin infections

Transmissibility of livestock-associated methicillin-resistant Staphylococcus aureus (ST398) in Dutch hospitals M.W.M. Wassenberg, M.C.J. Bootsma, A.

Emergence of dalbavancin non-susceptible, vancomycin-intermediate Staphylococcus aureus (VISA) after treatment of MRSA central line-associated bloodstream.

M. Aires-de-Sousa Clinical Microbiology and Infection

O. Murillo, I. Grau, J. Lora-Tamayo, J. Gomez-Junyent, A. Ribera, F

Comparison of vancomycin and linezolid in patients with peripheral vascular disease and/or diabetes in an observational European study of complicated.

Y. Tveten, A. Jenkins, A.G. Allum, B.-E. Kristiansen

Effectiveness of a hospital-wide selective screening programme for methicillin-resistant Staphylococcus aureus (MRSA) carriers at hospital admission to.

ST2249-MRSA-III: a second major recombinant methicillin-resistant Staphylococcus aureus clone causing healthcare infection in the 1970s G.R. Nimmo, J.A.

Methicillin-resistant Staphylococcus aureus (MRSA) with reduced susceptibility to glycopeptides (GISA) in 63 French general hospitals G.L. Cartolano,

P.M. Hawkey Clinical Microbiology and Infection

Increased incidence of methicillin-resistant Staphylococcus aureus ST80, novel ST125 and SCCmecIV in the south-eastern part of Norway during a 12-year.

Community-associated Staphylococcus aureus infections and nasal carriage among children: molecular microbial data and clinical characteristics G. Sdougkos,

G.M. Rossolini, E. Mantengoli Clinical Microbiology and Infection

J.-M. Rolain, C. Abat, P. Brouqui, D. Raoult

Predictors of clinical and microbiological treatment failure in patients with methicillin- resistant Staphylococcus aureus (MRSA) bacteraemia: a retrospective.

Rise and subsequent decline of community-associated methicillin resistant Staphylococcus aureus ST30-IVc in Copenhagen, Denmark through an effective search.

Panton–Valentine leukocidin-encoding bacteriophage and gene sequence variation in community-associated methicillin-resistant Staphylococcus aureus J.A.

Cost-effectiveness of adding decolonization to a surveillance strategy of screening and isolation for methicillin-resistant Staphylococcus aureus carriers

J. Wilson, S. Elgohari, D. M. Livermore, B. Cookson, A. Johnson, T

A. Manzur, F. Gudiol Clinical Microbiology and Infection

W. Witte Clinical Microbiology and Infection

B.A. Cunha Clinical Microbiology and Infection

J.L. Balcázar Clinical Microbiology and Infection

G.C. Schito Clinical Microbiology and Infection

H. Ghasemzadeh-Moghaddam, V. Neela, W. van Wamel, R. A. Hamat, M

D.A. Robinson, M.C. Enright Clinical Microbiology and Infection

Derek Y. Hsu, BA, Kenneth Gordon, MD, Jonathan I

Cefazolin versus anti-staphylococcal penicillins for the treatment of patients with Staphylococcus aureus bacteraemia S. Weis, M. Kesselmeier, J.S. Davis,

The burden of chikungunya in the Pacific

Presentation transcript:

Comparing a single-day swabbing regimen with an established 3-day protocol for MRSA decolonization control H. Frickmann, N.G. Schwarz, A. Hahn, A. Ludyga, P. Warnke, A. Podbielski Clinical Microbiology and Infection Volume 24, Issue 5, Pages 522-527 (May 2018) DOI: 10.1016/j.cmi.2017.08.022 Copyright © 2017 The Authors Terms and Conditions

Fig. 1 Patient counts after application of exclusion criteria. Clinical Microbiology and Infection 2018 24, 522-527DOI: (10.1016/j.cmi.2017.08.022) Copyright © 2017 The Authors Terms and Conditions

Fig. 2 Assessment of noninferiority regarding methicillin-resistant Staphylococcus aureus positivity of three-on-one-day nasal swab scheme compared to comparative standard scheme (with one swab per day for 3 days). Change (δ) of 15%, p 0.0023. One-sided test of proportion tested for noninferiority with significance level of 5% (one-sided 95% confidence interval on left side). N-I margin, noninferiority margin. Clinical Microbiology and Infection 2018 24, 522-527DOI: (10.1016/j.cmi.2017.08.022) Copyright © 2017 The Authors Terms and Conditions

Fig. 3 Assessment of noninferiority regarding methicillin-resistant Staphylococcus aureus positivity of three-on-one-day throat swab scheme compared to comparative standard scheme (with one swab per day for 3 days). Change (δ) of 15%, p 0.0097. One-sided test of proportion tested for noninferiority with significance level of 5% (one-sided 95% confidence interval on left side). N-I margin, noninferiority margin. Clinical Microbiology and Infection 2018 24, 522-527DOI: (10.1016/j.cmi.2017.08.022) Copyright © 2017 The Authors Terms and Conditions

Clinical Microbiology and Infection 2018 24, 522-527DOI: (10. 1016/j Clinical Microbiology and Infection 2018 24, 522-527DOI: (10.1016/j.cmi.2017.08.022) Copyright © 2017 The Authors Terms and Conditions